Skip to main content

NALP4 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-31375

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-31375
NBP2-31375SS

Key Product Details

Species Reactivity

Human

Applications

Immunocytochemistry/ Immunofluorescence, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

1.0 mg/ml

Product Specifications

Immunogen

Partial recombinant human NALP4 protein (between residues 1-300) [UniProt Q96MN2]

Reactivity Notes

Immunogen shows 51% similarity with Mouse's NALP4.

Localization

Cytoplasm

Specificity

Besides detecting canonical isoform (~113.4 kDa), this antibody may detect isoform 3 (104 kDa) also.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for NALP4 Antibody

Western Blot: NALP4 Antibody [NBP2-31375]

Western Blot: NALP4 Antibody [NBP2-31375]

Western Blot: NALP4 Antibody [NBP2-31375] - WB detection of NALP4/ NLRP4 protein in (A) K562 cell lysate and (B) partial recombinant protein by using NALP4 antibody at a concentration of: 1 ug/ml for lysate and 0.05 ug/ml for recombinant protein. In K562 cells lysate, this antibody detected a single specific band at ~116 kDa position (predicted size of NALP4 is 113.4 kDa).
Immunocytochemistry/ Immunofluorescence: NALP4 Antibody [NBP2-31375]

Immunocytochemistry/ Immunofluorescence: NALP4 Antibody [NBP2-31375]

Immunocytochemistry/Immunofluorescence: NALP4 Antibody [NBP2-31375] - NALP4 antibody was tested in MCF7 cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red). An antibody concentration of 0.1 ug/ml was used. Image objective 40x.

Applications for NALP4 Antibody

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

0.1 ug/ml

Western Blot

1-2 ug/ml

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: NALP4

NALP proteins include the apoptosis regulator APAF1 (apoptotic protease activating factor 1) and mammalian NOD-LRR proteins and are thought to be involved in inflammation and reproduction. NALP4, also known as PYRIN-containing APAF1-like protein 4, has a C-terminal leucine-rich repeat (LRR) region, an N-terminal Pyrin domain (PYD) followed by a NACHT domain, and a NACHT-associated domain. In transfected 293 cells, NALP4 suppressed NF-kappaB induction by TNF-alpha and IL-1beta, suggesting NALP4 operates at a point of convergence in these two signaling pathways. NALP4 also suppressed NF-kappaB induction resulting from overexpression of several adapter proteins and protein kinases involved in these pathways, including TRAF2, TRAF6, RIP, and IRAK2, as well as the IKK-alpha and IKK-beta, suggesting that NALP4 is critical in modulating NF-kappaB activity.

Alternate Names

Cancer/testis antigen 58, CLR19.5, CT58PYRIN and NACHT-containing protein 2, FLJ32126, NACHT, leucine rich repeat and PYD containing 4, NACHT, LRR and PYD domains-containing protein 4, NALP4NACHT, LRR and PYD containing protein 4, NLR family, pyrin domain containing 4, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 4, PAN2Ribonuclease inhibitor 2, PYPAF4PAAD and NACHT-containing protein 2, RNH2PYRIN-containing APAF1-like protein 4

Entrez Gene IDs

147945 (Human)

Gene Symbol

NLRP4

UniProt

Additional NALP4 Products

Product Documents for NALP4 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for NALP4 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...